AR027763A1 - Tratamiento de trastornos renales - Google Patents
Tratamiento de trastornos renalesInfo
- Publication number
- AR027763A1 AR027763A1 ARP010101580A ARP010101580A AR027763A1 AR 027763 A1 AR027763 A1 AR 027763A1 AR P010101580 A ARP010101580 A AR P010101580A AR P010101580 A ARP010101580 A AR P010101580A AR 027763 A1 AR027763 A1 AR 027763A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- renal disorders
- amlodipine
- cats
- renal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0008332.9A GB0008332D0 (en) | 2000-04-04 | 2000-04-04 | Treament |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027763A1 true AR027763A1 (es) | 2003-04-09 |
Family
ID=9889228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101580A AR027763A1 (es) | 2000-04-04 | 2001-04-03 | Tratamiento de trastornos renales |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1284719A2 (fr) |
JP (1) | JP2003528927A (fr) |
AR (1) | AR027763A1 (fr) |
AU (1) | AU2001239510A1 (fr) |
BR (1) | BR0109783A (fr) |
CA (1) | CA2403950A1 (fr) |
GB (1) | GB0008332D0 (fr) |
MX (1) | MXPA02009819A (fr) |
PA (1) | PA8514601A1 (fr) |
PE (1) | PE20011163A1 (fr) |
TN (1) | TNSN01051A1 (fr) |
WO (1) | WO2001074390A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1345901A2 (fr) * | 2000-12-29 | 2003-09-24 | Bioorganics B.V. | Procede de fabrication de l'amlodipine, derives de l'amlodipine et precurseurs associes |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
AT5874U1 (de) * | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
SI1443917T1 (sl) * | 2001-11-07 | 2006-06-30 | Synthon Bv | Tablete tamsulozina |
NL1019882C2 (nl) * | 2002-02-01 | 2003-08-04 | Synthon Licensing | Amlodipine vrije base. |
CO5400144A1 (es) | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
JP4418753B2 (ja) * | 2002-09-30 | 2010-02-24 | 興和株式会社 | 腎疾患の予防及び治療用医薬組成物 |
NZ541454A (en) | 2003-01-31 | 2008-04-30 | Daiichi Sankyo Co Ltd | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
WO2006085208A2 (fr) * | 2005-02-11 | 2006-08-17 | Ranbaxy Laboratories Limited | Formes galeniques solides stables d'amlodipine et de benazepril |
WO2006097943A2 (fr) | 2005-03-15 | 2006-09-21 | Lupin Limited | Compositions pharmaceutiques d'amlodipine et de benazepril. |
RU2398447C2 (ru) * | 2005-04-29 | 2010-09-10 | Хилл'С Пет Ньютришн, Инк. | Способы увеличения продолжительности жизни кошек |
EP3434284A4 (fr) * | 2016-03-24 | 2019-11-13 | Daiichi Sankyo Company, Limited | Médicament pour le traitement d'une maladie rénale |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8710493D0 (en) * | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
EP0459666B1 (fr) * | 1990-05-31 | 1994-11-09 | Pfizer Inc. | Médicament contre l'impuissance |
NZ242724A (en) * | 1991-05-15 | 1994-09-27 | Du Pont | Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker |
CA2124445A1 (fr) * | 1991-11-26 | 1993-06-10 | James W. Young | Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres troubles par la (-) amlodipine optiquement pure |
PT804229E (pt) * | 1995-03-16 | 2003-06-30 | Pfizer | Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica |
EP0795327A1 (fr) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Utilisation de l'amlodipine pour le traitement et la prophylaxie de l'insuffisance cardiaque congestive d'origine non-ischémique |
-
2000
- 2000-04-04 GB GBGB0008332.9A patent/GB0008332D0/en not_active Ceased
-
2001
- 2001-03-28 MX MXPA02009819A patent/MXPA02009819A/es unknown
- 2001-03-28 JP JP2001572132A patent/JP2003528927A/ja not_active Abandoned
- 2001-03-28 WO PCT/IB2001/000518 patent/WO2001074390A2/fr not_active Application Discontinuation
- 2001-03-28 AU AU2001239510A patent/AU2001239510A1/en not_active Abandoned
- 2001-03-28 EP EP01914134A patent/EP1284719A2/fr not_active Withdrawn
- 2001-03-28 BR BR0109783-0A patent/BR0109783A/pt not_active IP Right Cessation
- 2001-03-28 CA CA002403950A patent/CA2403950A1/fr not_active Abandoned
- 2001-04-02 PE PE2001000305A patent/PE20011163A1/es not_active Application Discontinuation
- 2001-04-03 PA PA20018514601A patent/PA8514601A1/es unknown
- 2001-04-03 AR ARP010101580A patent/AR027763A1/es not_active Application Discontinuation
- 2001-04-03 TN TNTNSN01051A patent/TNSN01051A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
TNSN01051A1 (fr) | 2005-11-10 |
CA2403950A1 (fr) | 2001-10-11 |
WO2001074390A3 (fr) | 2002-05-30 |
BR0109783A (pt) | 2003-01-21 |
GB0008332D0 (en) | 2000-05-24 |
EP1284719A2 (fr) | 2003-02-26 |
AU2001239510A1 (en) | 2001-10-15 |
PE20011163A1 (es) | 2001-11-12 |
MXPA02009819A (es) | 2003-03-27 |
PA8514601A1 (es) | 2002-08-26 |
JP2003528927A (ja) | 2003-09-30 |
WO2001074390A2 (fr) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0311275A2 (pt) | "composições de fenofibrato estáveis para administração oral, bem como uso das mesmas" | |
EA200501430A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
EA200301213A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
UY27098A1 (es) | Derivados de indol | |
BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
AR027763A1 (es) | Tratamiento de trastornos renales | |
BRPI0416936A (pt) | sistemas de anel de imidazo substituìdos e métodos | |
AR069830A1 (es) | Factor viii y factor de von willebrand recombinantes modificados y metodos de uso de los mismos | |
CL2007001918A1 (es) | Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras. | |
BRPI9907866B8 (pt) | composição farmacêutica, bem como seu uso | |
PA8577001A1 (es) | Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos | |
ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
BR0015254B1 (pt) | compostos derivados de carbamoiloxialquil-azàlio, seu uso, bem como composiÇço farmacÊutica compreendendo os mesmos. | |
SV2008002906A (es) | Metodos y composiciones para modular la hemostasiaref. cho.0267b-sv | |
AR056080A1 (es) | 7-[2-[4-(6-fluoro-3-metil-1,2-benciosoxazol-5-il)-1-piperazinil]etil]-2-(1-propinil)-7h-pirazol-[4,3-e]-[1,2,4]-triazol-[1,5-c] -pirimidin-5-amine | |
SV2004001549A (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
DE60035639D1 (de) | Hydroxydiphenyletherverbindungen | |
PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
PA8532201A1 (es) | Derivados de fenil cetonas sustituidas como antagonistas de ip | |
BR0010702A (pt) | Novas quinonas como terapias de doenças | |
NO20055207L (no) | Oralt farmasoytisk preparat for protonpumpeantagonister | |
EA200602154A1 (ru) | Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5 | |
BR0209430B1 (pt) | compostos heterocíclicos, processo para sua preparação, composições para o combate de pragas animais, uso dos referidos compostos, bem como preparação das referidas composições | |
ECSP003590A (es) | Compuestos calcioliticos | |
ECSP034532A (es) | Derivados del 1-aminobutan-3-ol sustituido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |